Ameritas Advisory Services LLC Purchases 686 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Ameritas Advisory Services LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 9.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,668 shares of the healthcare conglomerate’s stock after purchasing an additional 686 shares during the period. Ameritas Advisory Services LLC’s holdings in UnitedHealth Group were worth $3,911,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. Outfitter Financial LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $25,000. Advocacy Wealth Management Services LLC grew its stake in shares of UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. grew its stake in shares of UnitedHealth Group by 100.0% during the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 30 shares during the last quarter. Tortoise Investment Management LLC grew its stake in shares of UnitedHealth Group by 54.8% during the fourth quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 23 shares during the last quarter. Finally, Leverty Financial Group LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $34,000. 87.48% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Morgan Stanley boosted their price target on UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. StockNews.com began coverage on UnitedHealth Group in a report on Thursday, March 31st. They set a “strong-buy” rating for the company. Credit Suisse Group upped their target price on UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. Barclays upped their target price on UnitedHealth Group from $495.00 to $565.00 and gave the stock an “overweight” rating in a report on Wednesday, March 30th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $549.00 to $556.00 in a report on Tuesday, July 19th. Three research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $582.50.

UnitedHealth Group Price Performance

Shares of UNH opened at $534.61 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.78 and a current ratio of 0.77. The company has a market capitalization of $501.56 billion, a P/E ratio of 27.92, a P/E/G ratio of 1.64 and a beta of 0.77. The business’s 50-day moving average is $500.41 and its two-hundred day moving average is $496.04.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The firm had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. During the same period last year, the firm earned $4.70 EPS. The company’s quarterly revenue was up 12.6% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 21.84 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Monday, June 20th were paid a $1.65 dividend. The ex-dividend date of this dividend was Thursday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 dividend on an annualized basis and a yield of 1.23%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.46%.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the sale, the chief executive officer now owns 76,559 shares in the company, valued at approximately $40,415,496.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,273 shares of the firm’s stock in a transaction that occurred on Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the sale, the executive vice president now owns 8,104 shares of the company’s stock, valued at approximately $4,043,896. The disclosure for this sale can be found here. Insiders have sold 17,649 shares of company stock valued at $9,071,142 in the last ninety days. 0.40% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.